News | News By Subject | News by Disease News By Date | Search News

Chronic Fatigue Syndrome News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web
Visual Stress Could Be A Symptom Of Chronic Fatigue Syndrome, University of Leicester Research Suggests     11/25/2015
Virus Disproved as Cause of Chronic Fatigue Syndrome, National Institutes of Health (NIH) Study     9/19/2012
Spinal Fluid May Hold Clues to Lyme Disease, Chronic Fatigue Syndrome, University of Medicine and Dentistry of New Jersey Study     2/25/2011
Therapy, Exercise Help Chronic Fatigue Syndrome, Radboud University Nijmegen Medical Centre Study     2/18/2011
Team Treatment Helps Depression, Chronic Disease, University of Washington Study     12/30/2010
Mystery Virus Still Keeping Secrets, Oxford University Study     10/14/2010
'Seven Genetic Types Of ME' Found, St George's Hospital, University of London Study     5/6/2008
Chronic Fatigue Syndrome Linked to Stomach Virus     9/14/2007
Small Trial Stirs Hope For Chronic Fatigue Patients     1/15/2007
Childhood Trauma Linked To Chronic Fatigue Syndrome In Adults     11/8/2006
Talking Therapy Treats "Fatigue"     9/29/2006
Arthritis Drug Might Reduce Fatigue In Cancer Patients     4/28/2006
Chronic Fatigue Syndrome Linked To Three Genes     4/21/2006
Australian Scientists Link Chronic Fatigue Syndrome To Glandular Fever     3/3/2006
Chronic Fatigue Gene Signs Found     7/21/2005

Press Releases
Hemispherx (HEB) Announces Identification Of High Responder Patient Subgroup From Ampligen Phase III Trial In Patients With CFS/ME     10/31/2016
Hemispherx (HEB) Announces Major Breakthrough: Approval For Commercial Sale Of Rintatolimod (U.S. Tradename: Ampligen) To Treat Severe Cases Of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) In The Argentine Republic     8/23/2016
Hemispherx (HEB): Dr. William M. Mitchell Publishes Article Titled, “Efficacy Of Rintatolimod In The Treatment Of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)” In Expert Review Of Clinical Pharmacology     6/7/2016
Hemispherx (HEB) Research Team Identifies Characteristics Of Chronic Fatigue Syndrome (CFS) Patients Potentially Predictive Of Improved Response To Ampligen     9/21/2015
Hemispherx (HEB) Reports Low NK Cell Activity in Chronic Fatigue Syndrome (CFS) and Relationship to Disease Symptoms     9/15/2015
Hemispherx Biopharma (HEB) Enters Into An Agreement With MyTomorrows For An Early Access Program For Rintatolimod In Europe     8/10/2015
Hemispherx Biopharma (HEB) Enters A Collaboration With Emerge Health For The Commercialization Of Ampligen For Chronic Fatigue Syndrome (CFS) In Australia And New Zealand     3/9/2015
Hemispherx Biopharma (HEB): Institute Of Medicine, The Health Arm Of The US National Academy of Sciences Reframes Chronic Fatigue Syndrome (CFS) As A "Systemic Exertion Intolerance Disease" (SEID)     2/23/2015
Hemispherx Biopharma (HEB) Release: Low Natural Killer (NK) Activity Observed Across The Chronic Fatigue Syndrome (CFS) Disease Spectrum     1/12/2015
The Open Medicine Institute (OMI) To Develop First-Ever Biomarkers For Chronic Fatigue Syndrome And A Range Of Complex Diseases     5/21/2014
Hemispherx Biopharma (HEB) Announces Plans To File For Regulatory Approval Of Ampligen® To Treat Chronic Fatigue Syndrome (CFS) In Three Additional Latin America Countries     3/11/2014
FDA to Hold Public Teleconference on October 16 on Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Drug Development     10/16/2013
FDA's Voice of the Patient Report on Chronic Fatigue Syndrome Reveals Disease Impact and Areas for Progress     10/8/2013
JPT Peptide Technologies GmbH and The Institute for Medical Immunology at the Charité in Berlin Announce Collaboration on Chronic Fatigue Syndrome     1/30/2013
Hemispherx Biopharma (HEB) Release: FDA Accepts Complete Response Submission Regarding the Ampligen® New Drug Application for Chronic Fatigue Syndrome     8/14/2012